Records containing: Stage IVA Nasopharyngeal Carcinoma AJCC v8
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-23A Randomized, Masked, Placebo Controlled, Phase II Trial Of Concurrent Chemoradiation With BMX-001 In Patients With Head And Neck Squamous Cell Carcinoma Receiving Concurrent Chemoradiation
-
CLINICAL_TRIALS study record update · 2026-04-16A Phase 2 Window of Opportunity Trial of Neoadjuvant Agonistic Anti-CD40 Antibody CDX-1140 and Cemiplimab (REGN2810) in AJCC Stage III-IV Head and Neck Cancer Patients Prior to Surgery
-
CLINICAL_TRIALS study record update · 2026-04-15Modeling Adherence to Preventive Swallowing Exercises in Head and Neck Cancer
-
CLINICAL_TRIALS study record update · 2025-04-20Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
-
CLINICAL_TRIALS study record update · 2024-09-19An Open-Label, Phase III Study of Platinum-Gemcitabine With or Without Nivolumab in the First-Line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma
- Organize your saved records without ads with Plus.